Insights & Events

July 31, 2026: Covered pharmaceutical articles of companies listed in Annex III to Proclamation 11020 become subject to the applicable Section 232 duty rate.
September 29, 2026: Covered pharmaceutical articles of all other companies become subject to the applicable Section 232 duty rate.
July 31, 2026 onward: All importers of goods classified under the subject Chapter 29 and Chapter 30 HTSUS classifications must report the applicable Chapter 99 HTSUS heading, regardless of whether additional duties are immediately payable.

Get the latest insights and industry news delivered straight to your inbox.

The Latest from Aprio

Webinars
Watch the latest webcasts for informative perspectives and insights from Aprio advisors.
Tax Alerts
Aprio’s tax alert hub brings together the latest federal and state tax updates, IRS guidance, and legislative developments our advisors are tracking across industries and practice areas.
Aprio Newsroom
Browse Aprio press releases for the latest news on Aprio, our people, and the markets we proudly serve.
Tariffs Watch
The U.S. Supreme Court has stroked down a significant portion of President Trump’s tariff agenda, stating that only Congress can levy duties. The path forward for trade policy and refunds remains unclear.
Podcasts
Hear all the latest insights from your trusted Aprio advisors.
One Big Beautiful Bill
Aprio’s Tax advisors have prepared a comprehensive overview of the bill, as well as a deep dive into the many notable provisions.
Client Success Stories
Explore real client stories that show how Aprio advisors help uncover savings, reduce risk, and support growth.
Economic Analysis
Read outlooks, commentary on the economy and capital markets, private capital insights and industry reports from Aprio CFO, Simeon Wallis.